Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung ...

A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary ...

Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Mar. 25, 2025 — Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor ...

BBT-877, a substance introduced from LigaChem Biosciences, works by selectively inhibiting autotaxin, a protein that causes pulmonary fibrosis, and is being developed as a first-in-class treatment ...

I would wake up in the morning with dread thinking, I’ve got to go through this day and I don't want to because it's so hard.” As the Ohio resident’s lung disease worsened, her world became smaller.

First-ever use of Ebenbuild’s Twinhale technology in idiopathic pulmonary fibrosis lung models Trial results published in Nature Communications ...

There are over 100 types of interstitial lung disease. Age, genetics, smoking, and medical treatments can all predispose a ...